MKSI on Nasdaq
MKS INC
American industrial instruments for measurement company based in Andover2
In its 2026 annual report the company says: “We deliver foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. We apply our broad science and engineering capabilities to create instruments, subsystems, systems, process control solutions and specialty chemicals technology that improve process performance, optimize productivity and enable unique innovations for many of the world’s leading technology and industrial companies.”6 Its shares trade on Nasdaq under the symbol MKSI.2
$225.48 down 9.02 (3.85%)Price as of Oct 15, 2026 at 17:33 UTC
Last updated Oct 21, 2026.
Overview
Compare with Fortive, Sensata Technologies Holding plc or Keysight Technologies, or pick any stock.
- TickerMKSI on Nasdaq2
- IndustryIndustrial Instruments For Measurement, Display, and Control2
- HeadquartersAndover, United States2
- Incorporated inMA4
- Business address2 Tech Drive, Andover, Ma 018104
- Filer categoryLarge accelerated filer4
- Legal formDomestic Business Corporation2
- LEI549300KEQATBHAGVF5052
- StatusActive2
- LEI statusIssued and current2
- Registered addressC/O COGENCY GLOBAL INC., 02108 Boston, United States2
- Registered withCorporations Division (Secretary of the Commonwealth's Office), 0422775122
See how the biggest companies compare on our leaderboards
MKS Inc., formerly known as MKS Instruments, Inc. (“MKS,” the “Company,” “our,” or “we”), was founded in 1961 as a Massachusetts corporation. We enable technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. We apply our broad science and engineering capabilities to create instruments, subsystems, systems, process control solutions and specialty chemicals technology that improve process performance, optimize productivity and enable unique innovations for many of the world’s leading technology and industrial companies. Our solutions are critical to addressing the challenges of miniaturization and complexity in advanced device manufacturing by enabling increased power, speed, feature enhancement and optimized connectivity. Our solutions are also critica…6 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
46.7%Gross margin7
13.4%Operating margin7
7.5%Net margin7
9.6%Revenue growth, 20257
10.8%Return on equity7
1.53×Debt to equity7
$497.0MFree cash flow7
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Semiconductor brought in 43% of the revenue MKS INC broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Semiconductor | $1.5B | $1.5B | $1.7B |
| Specialty Industrial | $1.2B | $1.2B | $1.1B |
| Electronics and Packaging | $916.0M | $922.0M | $1.1B |
Business segments
Vacuum Solutions Division brought in 40% of the revenue MKS INC broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Vacuum Solutions Division | $1.4B | $1.4B | $1.6B |
| Materials Solutions Division | $1.2B | $1.2B | $1.3B |
| Photonics Solutions Division | $976.0M | $1.0B | $1.0B |
Regions
Other Countries brought in 26% of the revenue MKS INC broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| Other Countries | $858.0M | $936.0M | $1.0B |
| China | $745.0M | $775.0M | $931.0M |
| United States | $893.0M | $804.0M | $760.0M |
| South Korea | $359.0M | $358.0M | $440.0M |
| Singapore | $239.0M | $229.0M | $265.0M |
| Taiwan | $248.0M | $234.0M | $260.0M |
| Japan | $280.0M | $250.0M | $240.0M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Research and development8¢$299.0M
- Selling, general and admin18¢$724.0M
- Other costs61¢$2.4B
- Interest5¢$212.0M
- Income tax0¢$9.0M
- Profit8¢$295.0M
Out of $3.9B in revenue.7
Where each dollar of operating cash went, fiscal 2025
- Capital spending23¢$148.0M
- Dividends paid9¢$59.0M
- Share buybacks7¢$45.0M
- Kept or used elsewhere61¢$393.0M
Out of $645.0M of cash from operations.7
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net revenues | $3.9B | $3.6B | $3.6B |
| Cost of revenues | $2.1B | $1.9B | $2.0B |
| Gross profit | $1.8B | $1.7B | $1.6B |
| Research and development | $299.0M | $271.0M | $288.0M |
| Selling, general and administrative | $724.0M | $674.0M | $675.0M |
| Acquisition and integration costs | $0 | $9.0M | $16.0M |
| Restructuring and other | $37.0M | $6.0M | $20.0M |
| Fees and expenses related to amendments to the Term Loan Facility | $2.0M | $5.0M | $2.0M |
| Amortization of intangible assets | $247.0M | $245.0M | $295.0M |
| Goodwill and intangible asset impairments | $0 | $0 | $1.9B |
| Gain on sale of long-lived assets | $0 | $0 | -$2.0M |
| Income (loss) from operations | $528.0M | $498.0M | -$1.6B |
| Interest income | -$14.0M | -$21.0M | -$17.0M |
| Interest expense | $212.0M | $284.0M | $356.0M |
| Loss on extinguishment of debt | -$10.0M | -$57.0M | -$8.0M |
| Other expense (income), net | $16.0M | -$2.0M | $27.0M |
| Income (loss) before income taxes | $304.0M | $180.0M | -$1.9B |
| (Benefit) provision for income taxes | $9.0M | -$10.0M | -$87.0M |
| Net income (loss) | $295.0M | $190.0M | -$1.8B |
| Changes in value of financial instruments designated as cash flow hedges | -$29.0M | -$1.0M | -$24.0M |
| Foreign currency translation adjustments | $237.0M | -$213.0M | -$83.0M |
| Change in net investment hedge | -$63.0M | $36.0M | -$25.0M |
| Unrecognized pension gain (loss) | $10.0M | $3.0M | -$9.0M |
| Unrealized gain (loss) on investments | $0 | $23.0M | -$23.0M |
| Total comprehensive income (loss) | $450.0M | $38.0M | -$2.0B |
| Basic | $4.39 | $2.82 | -$27.54 |
| Diluted | $4.37 | $2.81 | -$27.54 |
| Basic | 67.3M shares | 67.3M shares | 66.8M shares |
| Diluted | 67.7M shares | 67.6M shares | 66.8M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $675.0M | $714.0M | ||
| Trade accounts receivable, net of allowance for doubtful accounts of $5 at both December 31, 2025 and 2024 | $651.0M | $615.0M | ||
| Inventories | $921.0M | $893.0M | ||
| Other current assets | $263.0M | $252.0M | ||
| Total current assets | $2.5B | $2.5B | ||
| Property, plant and equipment, net | $810.0M | $771.0M | ||
| Right-of-use assets | $270.0M | $238.0M | ||
| Goodwill | $2.6B | $2.5B | ||
| Intangible assets, net | $2.1B | $2.3B | ||
| Other assets | $492.0M | $356.0M | ||
| Total assets | $8.8B | $8.6B | ||
| Short-term debt | $51.0M | $50.0M | ||
| Accounts payable | $407.0M | $341.0M | ||
| Other current liabilities | $469.0M | $384.0M | ||
| Total current liabilities | $927.0M | $775.0M | ||
| Long-term debt, net | $4.2B | $4.5B | ||
| Non-current deferred taxes | $474.0M | $504.0M | ||
| Non-current accrued compensation | $149.0M | $141.0M | ||
| Non-current lease liabilities | $246.0M | $211.0M | ||
| Other non-current liabilities | $131.0M | $149.0M | ||
| Total liabilities | $6.1B | $6.3B | ||
| Common stock, no par value, 200 shares authorized; 67.2 and 67.4 shares issued and outstanding at December 31, 2025 and 2024, respectively | $0 | $0 | ||
| Additional paid-in capital | $2.1B | $2.1B | ||
| Retained earnings | $711.0M | $503.0M | ||
| Accumulated other comprehensive loss | -$93.0M | -$248.0M | ||
| Total stockholders equity | $2.7B | $2.3B | $2.5B | $4.5B |
| Total liabilities and stockholders' equity | $8.8B | $8.6B | ||
| Allowance for doubtful accounts | $5.0M | $5.0M | ||
| Preferred stock, par value | $0.01 | $0.01 | ||
| Preferred stock, shares authorized | 2.0M shares | 2.0M shares | ||
| Preferred stock, shares issued | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding | 0 shares | 0 shares | ||
| Common stock, par value | $0 | $0 | ||
| Common stock, shares authorized | 200.0M shares | 200.0M shares | ||
| Common stock, shares issued | 67.2M shares | 67.4M shares | ||
| Common stock, shares outstanding | 67.2M shares | 67.4M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $675.0M | $714.0M | ||
| Trade accounts receivable, net of allowance for doubtful accounts of $5 at both December 31, 2025 and 2024 | $651.0M | $615.0M | ||
| Inventories | $921.0M | $893.0M | ||
| Other current assets | $263.0M | $252.0M | ||
| Total current assets | $2.5B | $2.5B | ||
| Property, plant and equipment, net | $810.0M | $771.0M | ||
| Right-of-use assets | $270.0M | $238.0M | ||
| Goodwill | $2.6B | $2.5B | ||
| Intangible assets, net | $2.1B | $2.3B | ||
| Other assets | $492.0M | $356.0M | ||
| Total assets | $8.8B | $8.6B | ||
| Short-term debt | $51.0M | $50.0M | ||
| Accounts payable | $407.0M | $341.0M | ||
| Other current liabilities | $469.0M | $384.0M | ||
| Total current liabilities | $927.0M | $775.0M | ||
| Long-term debt, net | $4.2B | $4.5B | ||
| Non-current deferred taxes | $474.0M | $504.0M | ||
| Non-current accrued compensation | $149.0M | $141.0M | ||
| Non-current lease liabilities | $246.0M | $211.0M | ||
| Other non-current liabilities | $131.0M | $149.0M | ||
| Total liabilities | $6.1B | $6.3B | ||
| Common stock, no par value, 200 shares authorized; 67.2 and 67.4 shares issued and outstanding at December 31, 2025 and 2024, respectively | $0 | $0 | ||
| Additional paid-in capital | $2.1B | $2.1B | ||
| Retained earnings | $711.0M | $503.0M | ||
| Accumulated other comprehensive loss | -$93.0M | -$248.0M | ||
| Total stockholders equity | $2.7B | $2.3B | $2.5B | $4.5B |
| Total liabilities and stockholders' equity | $8.8B | $8.6B | ||
| Allowance for doubtful accounts | $5.0M | $5.0M | ||
| Preferred stock, par value | $0.01 | $0.01 | ||
| Preferred stock, shares authorized | 2.0M shares | 2.0M shares | ||
| Preferred stock, shares issued | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding | 0 shares | 0 shares | ||
| Common stock, par value | $0 | $0 | ||
| Common stock, shares authorized | 200.0M shares | 200.0M shares | ||
| Common stock, shares issued | 67.2M shares | 67.4M shares | ||
| Common stock, shares outstanding | 67.2M shares | 67.4M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income (loss) | $295.0M | $190.0M | -$1.8B |
| Depreciation and amortization | $344.0M | $348.0M | $397.0M |
| Goodwill and intangible asset impairments | $0 | $0 | $1.9B |
| Unrealized (gain) loss on foreign currency and derivative instruments | -$9.0M | $13.0M | $32.0M |
| Amortization of debt issuance costs and original issue discount | $26.0M | $30.0M | $33.0M |
| Loss on extinguishment of debt | $10.0M | $57.0M | $8.0M |
| Gain on sale of long-lived assets | $0 | $0 | -$2.0M |
| Stock-based compensation | $55.0M | $48.0M | $54.0M |
| Provision for excess and obsolete inventory | $45.0M | $56.0M | $64.0M |
| Deferred income taxes | -$196.0M | -$226.0M | -$234.0M |
| Other | $0 | $8.0M | $5.0M |
| Trade accounts receivable | -$16.0M | -$36.0M | $114.0M |
| Inventories | -$50.0M | $20.0M | -$76.0M |
| Other current and non-current assets | $14.0M | $25.0M | $50.0M |
| Accounts payable | $55.0M | $21.0M | -$99.0M |
| Current and non-current accrued compensation | $83.0M | -$32.0M | -$5.0M |
| Income taxes payable | $21.0M | $49.0M | -$64.0M |
| Other current and non-current liabilities | -$32.0M | -$43.0M | -$19.0M |
| Net cash provided by operating activities | $645.0M | $528.0M | $319.0M |
| Proceeds from sale of long-lived assets | $3.0M | $1.0M | $3.0M |
| Purchases of property, plant and equipment | -$148.0M | -$118.0M | -$87.0M |
| Net cash used in investing activities | -$145.0M | -$117.0M | -$84.0M |
| Repurchase of common stock | -$45.0M | $0 | $0 |
| Proceeds from borrowing | $0 | $2.2B | $216.0M |
| Payments of borrowings | -$451.0M | -$2.4B | -$403.0M |
| Purchase of capped calls related to Convertible Notes | $0 | -$167.0M | $0 |
| Payments of deferred financing fees | $0 | -$33.0M | -$9.0M |
| Dividend payments | -$59.0M | -$59.0M | -$59.0M |
| Net payments related to employee stock awards | -$4.0M | -$9.0M | -$1.0M |
| Other financing activities | -$3.0M | -$15.0M | -$3.0M |
| Net cash used in financing activities | -$562.0M | -$549.0M | -$259.0M |
| Effect of exchange rate changes on cash and cash equivalents | $23.0M | -$23.0M | -$10.0M |
| Decrease in cash and cash equivalents | -$39.0M | -$161.0M | -$34.0M |
| Interest | $190.0M | $268.0M | $305.0M |
| Right of use assets obtained in exchange for new finance lease liabilities | $46.0M | $12.0M | $1.0M |
No quarter-by-quarter statement was filed.
Corporate structure
MKS INC sits at the top of its group. 88 entities, 34 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of MKS INC
- JPMorgan Chase Filed SCHEDULE 13G/A on MKS INC, latest Sep 3, 2026 (2 filings since Jul 16, 2026)
- VICTORY CAPITAL MANAGEMENT INC Filed SCHEDULE 13G/A on MKS INC, latest Jul 24, 2026 (5 filings since Feb 2, 2023)
- FMR LLC Filed SCHEDULE 13G/A on MKS INC, latest May 6, 2026 (2 filings since Feb 9, 2024)
- VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on MKS INC, latest Apr 30, 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC Filed SCHEDULE 13G on MKS INC, latest Apr 29, 2026
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on MKS INC, latest Mar 27, 2026 (6 filings since Feb 10, 2022)
- PRICE T ROWE ASSOCIATES INC /MD/ Filed SCHEDULE 13G/A on MKS INC, latest Feb 17, 2026 (6 filings since Jan 10, 2024)
- Invesco Filed SCHEDULE 13G on MKS INC, latest Feb 12, 2026
- BlackRock Filed SCHEDULE 13G/A on MKS INC, latest Oct 17, 2025 (5 filings since Feb 1, 2022)
- Capital International Investors Filed SCHEDULE 13G/A on MKS INC, latest Feb 7, 2025 (5 filings since Feb 11, 2022)
- Carlyle Group Filed SC 13G/A on MKS INC, latest Feb 12, 2024 (2 filings since Aug 29, 2022)
- Wellington Management Company Filed SC 13G/A on MKS INC, latest Feb 6, 2023 (2 filings since Feb 4, 2022)
- MKS INC Andover, Massachusetts, United States
- Electro Scientific Industries Beaverton, Oregon, United States
- Alpha 2 B.V. Subsidiary · Netherlands
- Alpha 3 B.V. Subsidiary · Netherlands
- Alpha 4 B.V. Subsidiary · Netherlands
- Alpha Germany Bidco GmbH Subsidiary · Germany
- Alpha Treasury Services B.V. Subsidiary · Netherlands
- Atotech (China) Chemicals Ltd. Subsidiary · China
- Atotech (Malaysia) Sdn. Bhd. Subsidiary · Malaysia
- Atotech (Philippines) Chemicals, Inc. Subsidiary · Philippines
- Atotech (Singapore) Chemicals Pte. Ltd. Subsidiary · Singapore
- Atotech (Thailand) Co., Ltd. Subsidiary · Thailand
- Atotech (Yangzhou) Chemicals Ltd. Subsidiary · China
- Atotech Argentina SA Subsidiary · Argentina
- Atotech Asia Pacific Limited Subsidiary · Hong Kong
- Atotech Asset Management GmbH Subsidiary · Germany
- Atotech B.V. Subsidiary · Netherlands
- Atotech Beteiligungs und Management GmbH & Co. KG Subsidiary · Germany
- Atotech Canada Ltd. Subsidiary · Canada
- Atotech CZ, a.s. Subsidiary · Czechia
- Atotech de Mexico S.A. de C.V. Subsidiary · Mexico
- Atotech Deutschland GmbH & Co. KG Subsidiary · Germany
- Atotech Development Center Private Limited Subsidiary · India
- Atotech do Brasil Galvanotecnica Ltda. Subsidiary · Brazil
- Atotech España, S.A. Unipersonal Subsidiary · Spain
- Atotech France S.A.S Subsidiary · France
- and 62 more
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What MKS INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $1.7B7 Dec 31, 2025 | $1.5B7 Dec 31, 2024 | +10.7% |
| Accumulated depreciation | $859.0M7 Dec 31, 2025 | $736.0M7 Dec 31, 2024 | +16.7% |
| Property and equipment, net | $810.0M7 Dec 31, 2025 | $771.0M7 Dec 31, 2024 | +5.1% |
| Operating-lease assets (leased space) | $270.0M7 Dec 31, 2025 | $238.0M7 Dec 31, 2024 | +13.4% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $418.0M7 Dec 31, 2025 | $420.0M7 Dec 31, 2024 | −0.5% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $2.6B7 Dec 31, 2025 | $2.5B7 Dec 31, 2024 | +3.8% |
| Finite-lived intangibles, gross | $3.7B7 Dec 31, 2025 | $3.7B7 Dec 31, 2024 | 0% |
| Accumulated amortization | $1.4B7 Dec 31, 2025 | $1.1B7 Dec 31, 2024 | +22.4% |
| Finite-lived intangibles, net | $2.1B7 Dec 31, 2025 | $2.3B7 Dec 31, 2024 | −5.8% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $921.0M7 Dec 31, 2025 | $893.0M7 Dec 31, 2024 | +3.1% |
| Raw materials | $617.0M7 Dec 31, 2025 | $618.0M7 Dec 31, 2024 | −0.2% |
| Work in process | $116.0M7 Dec 31, 2025 | $97.0M7 Dec 31, 2024 | +19.6% |
| Finished goods | $188.0M7 Dec 31, 2025 | $178.0M7 Dec 31, 2024 | +5.6% |
Properties, in its own words
The following table provides information concerning MKS’ principal and certain other owned and leased facilities as of December 31, 2025:
Country · City · Sq. Ft. · Activity · Reportable Segment · Owned/Leased
The rest of Item 2
China · Guangzhou · 704,000 · Manufacturing, Warehouse, Sales, and Research and Development · MSD · Owned
Shenzhen · 293,000 · Manufacturing and Service · VSD · Leased
Yangzhou · 455,000 · Manufacturing, Warehouse, and Office · MSD · Owned
Germany · Berlin · 261,000 · Manufacturing, Office, and Research and Development · MSD · Leased
Feucht · 242,000 · Manufacturing, Warehouse, Office, and Research and Development · MSD · Owned
Neuruppin · 172,000 · Manufacturing, Warehouse, Office, and Research and Development · MSD · Owned
India · Manesar · 189,000 · Manufacturing and Research and Development · MSD · Owned
Mexico · Nogales · 124,000 · Manufacturing and Service · VSD and PSD · Leased
Romania · Bucharest · 131,000 · Manufacturing, Office, Research and Development, Service, and Warehouse · PSD · Leased
Slovenia · Podnart · 108,000 · Lab, Manufacturing, Office, Service, Warehouse, and Sales · MSD · Owned
South Korea · Hwaseong · 100,000 · Manufacturing, Sales, and Office · MSD · Owned
Yongin-si · 179,000 · Research and Development, Office, Warehouse, Service, and Sales · VSD · Owned
United States · Andover, MA · 76,000 · Corporate Headquarters, Manufacturing, and Research and Development · VSD · Leased
Beaverton, OR · 113,000 · Manufacturing, Office, and Warehouse · PSD · Leased
Broomfield, CO · 107,000 · Manufacturing and Research and Development · VSD · Leased
Irvine, CA · 191,000 · Manufacturing and Research and Development · PSD · Leased
Milpitas, CA · 103,000 · Manufacturing, Sales, Customer Support, Service, and Research and Development · PSD · Leased
Rochester, NY · 156,000 · Manufacturing, Sales, Customer Support, Service, and Research and Development · VSD · Owned
Rock Hill, SC · 200,000 · Manufacturing, Warehouse, Office, and Research and Development · MSD · Owned
Wilmington, MA · 118,000 · Manufacturing, Customer Support, Service, and Research and Development · VSD · Owned
In addition to the significant facilities listed above, MKS also has manufacturing, sales and marketing, customer support and services operations in various other leased and owned facilities throughout the world. See “Business—Sales and Marketing” and “Business—Reportable Segments, and Product and Service Offerings” in Part I, Item 1 of this Annual Report on Form 10-K. We believe that our current facilities are suitable and adequate to meet our needs.
Item 2 of the 10-K filed Feb 24, 2026.6
Leadership
Who has led MKS INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chair
Chief financial officer
Chief operating officer
2010201520202025
- Chief executive officerGerard G. Colella Feb 3, 2014 to Dec 10, 201915
- Chief executive officerLeo Berlinghieri Feb 15, 2006 to Dec 17, 201316
- ChairJohn R. Bertucci Jan 5, 2006 to Nov 13, 200617
- PresidentGerard G. Colella Feb 26, 2013 to May 2, 201818
- PresidentLeo Berlinghieri Feb 15, 2006 to Feb 1, 201316
- Chief financial officerRamakumar Mayampurath Oct 16, 2024 to now19
- Chief financial officerSeth H. Bagshaw Jan 8, 2010 to Feb 26, 202420
- Chief financial officerRonald Weigner Feb 15, 2006 to Jun 6, 200821
- Chief operating officerJames Alan Schreiner Jan 2, 2020 to now22
- Chief operating officerGerard G. Colella Feb 12, 2010 to Mar 12, 201323
Board members and other officers (33)
- EVP, GC & CCORenee Martel Donlan Jun 4, 2026 to now24
- VP & Chief Accounting OfficerMichelle M. McCarthy Mar 7, 2024 to now25
- SVP, Corp Mkt, PMO & Glob SvcDavid Philip Henry Feb 9, 2021 to now26
- SVP & GM, V&A DivisionEric Robert Taranto Feb 9, 2021 to now27
- SVP & GM, L&M DivisionMark Milton Gitin Feb 9, 2021 to Feb 16, 202428
- Sr. VP, GC & SecretaryKathleen Flaherty Burke May 9, 2019 to now29
- Sr. VP, Business UnitsDennis L. Werth May 5, 2016 to Apr 3, 201830
- Sr. VP, Global OperationsBrian Charles Quirk Mar 6, 2014 to May 8, 201831
- VP & GM, ENI and MedicalPaul Eyerman May 11, 2010 to Feb 3, 201432
- VP & GM, AstexPaul Loomis May 11, 2010 to Feb 3, 201433
- V.P., C.F.O & TreasurerRonald Weigner Feb 18, 2009 to Feb 12, 201034
- V.P. & General ManagerRobert L. Klimm Jan 19, 2006 to May 1, 200735
- V.P. General Manager CIT Prod.Ron Hadar Jan 19, 2006 to Jun 7, 200736
- Chief Business Officer and VPGerard G. Colella Feb 15, 2006 to Sep 21, 200937
- Board memberWissam G. Jabre Nov 5, 2024 to now38
- Board memberPeter Cannone Iii. May 12, 2021 to now39
- Board memberJanice K. Henry May 12, 2020 to May 12, 202040
- Board memberJoseph B. Donahue May 12, 2020 to now41
- Board memberMichelle M. Warner May 9, 2019 to May 8, 202442
- Board memberRick D. Hess May 10, 2017 to May 9, 201943
- Board memberJacqueline F. Moloney May 4, 2016 to now44
- Board memberRobert J. Phillippy Jul 6, 2016 to Feb 16, 201845
- Board memberGerard G. Colella Feb 3, 2014 to now15
- Board memberElizabeth Mora May 8, 2012 to now46
- Board memberPeter Hanley Mar 4, 2008 to Aug 8, 201847
- Board memberCristina Amon May 9, 2007 to Dec 17, 201548
- Board memberLeo Berlinghieri Feb 15, 2006 to Dec 17, 201316
- Board memberHans Jochen Kahl Feb 22, 2006 to May 3, 201149
- Board memberRichard S. Chute Feb 22, 2006 to May 9, 201950
- Board memberOwen W. Robbins Mar 6, 2006 to May 10, 200651
- Board memberJames G. Berges May 10, 2006 to May 10, 200652
- Board memberLouis P. Valente May 10, 2006 to Feb 7, 201253
- Board memberJohn R. Bertucci Dec 7, 2006 to May 9, 201954
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Alpha 2 B.V. Netherlands5
- Alpha 3 B.V. Netherlands5
- Alpha 4 B.V. Netherlands5
- Alpha Germany Bidco GmbH Germany5
- Alpha Treasury Services B.V. Netherlands5
- Atotech (China) Chemicals Ltd. China5
- Atotech (Malaysia) Sdn. Bhd. Malaysia5
- Atotech (Philippines) Chemicals, Inc. Philippines5
- Atotech (Singapore) Chemicals Pte. Ltd. Singapore5
- Atotech (Thailand) Co., Ltd. Thailand5
- Atotech (Yangzhou) Chemicals Ltd. China5
- Atotech Argentina SA Argentina5
- Atotech Asia Pacific Limited Hong Kong5
- Atotech Asset Management GmbH Germany5
- Atotech B.V. Netherlands5
- Atotech Beteiligungs und Management GmbH & Co. KG Germany5
- Atotech CZ, a.s. Czech Republic5
- Atotech Canada Ltd. Canada5
- Atotech Deutschland GmbH & Co. KG Germany5
- Atotech Development Center Private Limited India5
- Atotech España, S.A. Unipersonal Spain5
- Atotech France S.A.S France5
- Atotech Global Services Private Limited India5
- Atotech India Private Limited India5
All 91 listed subsidiaries
- Atotech Istanbul Kimya S. Ltd. Sirketi Turkey5
- Atotech Italia S.r.l. Italy5
- Atotech Japan K.K. Japan5
- Atotech Limited Jersey5
- Atotech Manufacturing, Inc. Delaware5
- Atotech Poland Sp. z.o.o. Poland5
- Atotech SK, s.r.o. Slovakia5
- Atotech Skandinavien AB Sweden5
- Atotech Slovenija d.d. Slovenia5
- Atotech Taiwan Ltd. Taiwan5
- Atotech UK Limited United Kingdom5
- Atotech USA, LLC Delaware5
- Atotech Vietnam Company Limited Vietnam5
- Atotech de Mexico S.A. de C.V. Mexico5
- Atotech do Brasil Galvanotecnica Ltda. Brazil5
- Atotech Österreich GmbH Austria5
- Atotech-Chemeta Limited Liability Company Russian Federation5
- ESI China, Inc. Oregon5
- ESI Electronic Equipment (Shanghai) Co., Ltd. China5
- ESI International Corporation Oregon5
- ESI Japan, K.K. Japan5
- ESI Vietnam Company Limited Vietnam5
- Electro Scientific Industries Europe Ltd United Kingdom5
- Electro Scientific Industries GmbH Germany5
- Electro Scientific Industries Singapore Pte. Ltd. Singapore5
- Electro Scientific Industries, Inc. Oregon5
- High Q Laser GmbH Austria5
- Hilger Analytical Limited United Kingdom5
- Iota Solutions Deutschland GmbH Germany5
- Iota Solutions Netherlands B.V. Netherlands5
- MKS Denmark ApS Denmark5
- MKS Instruments (China) Company Ltd. China5
- MKS Instruments (Hong Kong) Limited Hong Kong5
- MKS Instruments (Singapore) Pte. Ltd. Singapore5
- MKS Instruments (Thailand) Co., Ltd. Thailand5
- MKS Instruments Deutschland GmbH Germany5
- MKS Instruments ESI Switzerland GmbH Switzerland5
- MKS Instruments Holdings Ltd United Kingdom5
- MKS Instruments Israel Ltd. Israel5
- MKS Instruments Italy S.r.l. Italy5
- MKS Instruments Malaysia Sdn. Bhd. Malaysia5
- MKS Instruments Mexico S. de R.L. de C.V. Mexico5
- MKS Instruments UK Limited United Kingdom5
- MKS Japan, Inc. Japan5
- MKS Spectra Holdings Limited United Kingdom5
- MKS Taiwan Technology Limited Taiwan5
- Micro-Controle Spectra-Physics S.A.S. France5
- Newport Corporation Nevada5
- Newport Instruments Canada Corporation Canada5
- Newport Laser Holding GmbH Austria5
- Newport Ophir Holdings Ltd. Israel5
- Newport Opto-Electronics Technologies (Singapore) Pte. Ltd. Singapore5
- Newport Opto-Electronics Technologies (Wuxi) Company Limited China5
- Newport Spectra-Physics B.V. Netherlands5
- Newport Spectra-Physics GmbH Germany5
- Newport Spectra-Physics Limited United Kingdom5
- Ophir Japan Ltd. Japan5
- Ophir Optics S.R.L. Romania5
- Ophir Optronics Ltd. Israel5
- Ophir Optronics Solutions Ltd. Israel5
- Ophir Spiricon Europe GmbH Germany5
- Photon Control (USA) Inc. Delaware5
- Photon Control Inc. Canada5
- Pt. Atotech Indonesia Chemicals Indonesia5
- Spectra-Physics, K.K. Japan5
- Theta Solutions USA, LLC Delaware5
- V-Gen Ltd. Israel5
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
- MKS INSTRUMENTS INCNov 14, 1997 to May 15, 20254
Timeline
- Aug 5, 20268-K Results of operations55
- May 12, 20268-K Executive or director change; Shareholder vote56
- May 6, 20268-K Results of operations57
- Apr 6, 20268-K Executive or director change58
- Feb 17, 20268-K Results of operations59
- Feb 5, 20268-K Entered a material agreement; New debt or obligation; Regulation FD disclosure60
- Jan 28, 20268-K Other events61
- Jan 21, 20268-K Results of operations; Regulation FD disclosure62
- Nov 5, 20258-K Results of operations63
- Aug 6, 20258-K Results of operations64
- May 15, 20258-K Change to shareholders' rights; Executive or director change; Bylaws or fiscal year changed65
- May 7, 20258-K Results of operations66
- Feb 3, 2014New chief executive Gerard G. Colella becomes CEO15
- Feb 15, 2006New chief executive Leo Berlinghieri becomes CEO16
- Jun 14, 1961Founded MKS INC is founded2
Calendar
Coming up
- Nov 4, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $1.93 a share, on Nov 5, 2025.67
When it reported results
- Aug 5, 2026Reported quarterly or annual results55
- May 6, 2026Reported quarterly or annual results57
- Feb 17, 2026Reported quarterly or annual results59
- Jan 21, 2026Reported quarterly or annual results62
- Nov 5, 2025Reported quarterly or annual results63
- Aug 6, 2025Reported quarterly or annual results64
- May 7, 2025Reported quarterly or annual results66
- Feb 12, 2025Reported quarterly or annual results68
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
464 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 59 major events, 242 insider forms, 38 large holders, 105 other. The latest 20:
- Sep 3, 2026SCHEDULE 13G/A EDGAR
- Sep 2, 20264 PRIMARY DOCUMENT EDGAR
- Sep 1, 2026144 EDGAR
- Aug 18, 20264 PRIMARY DOCUMENT EDGAR
- Aug 17, 20264 PRIMARY DOCUMENT EDGAR
- Aug 14, 2026144 EDGAR
- Aug 6, 202610-Q EDGAR
- Aug 5, 20268-K EDGAR
- Aug 4, 20264 PRIMARY DOCUMENT EDGAR
- Aug 3, 2026144 EDGAR
- Jul 24, 2026SCHEDULE 13G/A EDGAR
- Jul 16, 2026SCHEDULE 13G EDGAR
- Jun 16, 20264 PRIMARY DOCUMENT EDGAR
- Jun 12, 2026144 EDGAR
- Jun 11, 20264 PRIMARY DOCUMENT EDGAR
- Jun 10, 2026144 EDGAR
- Jun 8, 20264 PRIMARY DOCUMENT EDGAR
- Jun 5, 2026144 EDGAR
- Jun 4, 20263 PRIMARY DOCUMENT EDGAR
- Jun 2, 20264 PRIMARY DOCUMENT EDGAR
The 464 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
83 open-market trades by officers, directors and large owners since October 2021: 3 buys and 80 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Mora ElizabethDirector | Sale | 300 | $250.96 | $75.3K | Form 4 |
| Aug 14, 2026 | Lee John Tseng-ChungPresident & CEO | Sale | 10,000 | $302.01 | $3.0M | Form 4 |
| Aug 3, 2026 | Williams John EdwardEVP & GM, PSD | Sale | 457 | $288.31 | $131.8K | Form 4 |
| Jun 12, 2026 | Schreiner James AlanEVP & COO | Sale | 3,500 | $345.82 | $1.2M | Form 4 |
| Jun 10, 2026 | Schreiner James AlanEVP & COO | Sale | 781 | $317.42 | $247.9K | Form 4 |
| Jun 5, 2026 | McCarthy Michelle MSVP & Chief Accounting Officer | Sale | 2,434 | $315.23 | $767.3K | Form 4 |
| Jun 1, 2026 | Henry David PhilipEVP, Global Str Mktg & GM, MSD | Sale | 6,000 | $314.43 | $1.9M | Form 4 |
| Jun 1, 2026 | Mora ElizabethDirector | Sale | 300 | $318.02 | $95.4K | Form 4 |
| May 27, 2026 | Donahue Joseph BDirector | Sale | 2,100 | $327.95 | $688.7K | Form 4 |
| May 27, 2026 | COLELLA GERALD GDirector | Sale | 20,000 | $333.40 | $6.7M | Form 4 |
| May 26, 2026 | Henry David PhilipEVP, Global Str Mktg & GM, MSD | Sale | 2,500 | $330.50 | $826.2K | Form 4 |
| May 22, 2026 | Mayampurath RamakumarEVP & CFO | Sale | 8,810 | $315.48 | $2.8M | Form 4 |
| May 22, 2026 | Lee John Tseng-ChungPresident & CEO | Sale | 10,000 | $315.48 | $3.2M | Form 4 |
| May 18, 2026 | CANNONE PETER IIIDirector | Sale | 1,350 | $303.40 | $409.6K | Form 4 |
| May 14, 2026 | Moloney Jacqueline FDirector | Sale | 1,000 | $312.20 | $312.2K | Form 4 |
| May 13, 2026 | Moloney Jacqueline FDirector | Sale | 1,400 | $318.99 | $446.6K | Form 4 |
| May 11, 2026 | Taranto Eric RobertEVP & GM, VSD | Sale | 2,849 | $319.93 | $911.3K | Form 4 |
| May 11, 2026 | Burke Kathleen FlahertyEVP, GC & Secretary | Sale | 4,355 | $319.94 | $1.4M | Form 4 |
| Mar 12, 2026 | Moloney Jacqueline FDirector | Sale | 340 | $213.77 | $72.7K | Form 4 |
| Mar 6, 2026 | Taranto Eric RobertEVP & GM, VSD | Sale | 4,568 | $220.52 | $1.0M | Form 4 |
All 83 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- JPMorgan ChaseSCHEDULE 13G/A, 2 filings Jul 16, 2026 to Sep 3, 202669
- VICTORY CAPITAL MANAGEMENT INCSCHEDULE 13G/A, 5 filings Feb 2, 2023 to Jul 24, 202670
- FMR LLCSCHEDULE 13G/A, 2 filings Feb 9, 2024 to May 6, 202671
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 30, 202672
- VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 202673
- VANGUARD GROUP INCSCHEDULE 13G/A, 6 filings Feb 10, 2022 to Mar 27, 202674
- PRICE T ROWE ASSOCIATES INC /MD/SCHEDULE 13G/A, 6 filings Jan 10, 2024 to Feb 17, 202675
- InvescoSCHEDULE 13G, 1 filing Feb 12, 202676
- BlackRockSCHEDULE 13G/A, 5 filings Feb 1, 2022 to Oct 17, 202577
- Capital International InvestorsSCHEDULE 13G/A, 5 filings Feb 11, 2022 to Feb 7, 202578
- Carlyle GroupSC 13G/A, 2 filings Aug 29, 2022 to Feb 12, 202479
- Wellington Management CompanySC 13G/A, 2 filings Feb 4, 2022 to Feb 6, 202380
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | President and CEO(principal executive officer) | $1.0M | $13.0M81 | |
| 2025 | EVP and CFO(principal financial officer) | $625.0K | $3.3M81 | |
| 2025 | EVP and COO | $541.4K | $2.9M81 | |
| 2025 | EVP, General Counseland Secretary | $542.5K | $2.8M81 | |
| 2025 | EVPGlobal Strategic Marketing, and General Manager, MSD | $525.8K | $2.4M81 | |
| 2024 | President and CEO(principal executive officer) | $970.5K | $8.8M81 | |
| 2024 | EVP and CFO(principal financial officer) | $134.9K | $2.9M81 | |
| 2024 | EVP and COO | $477.9K | $2.7M81 | |
| 2024 | EVP, General Counseland Secretary | $510.1K | $1.9M81 | |
| 2024 | EVPGlobal Strategic Marketing, and General Manager, MSD | $455.7K | $1.6M81 | |
| 2023 | President and CEO(principal executive officer) | $950.0K | $7.9M81 | |
| 2023 | EVP and COO | $465.7K | $2.0M81 | |
| 2023 | EVP, General Counseland Secretary | $504.0K | $1.9M81 | |
| 2023 | EVPGlobal Strategic Marketing, and General Manager, MSD | $450.0K | $1.5M81 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 6,930,030 | $3.1B | 0.0% | +288,300 |
| Invesco Ltd. | 4,661,664 | $2.1B | 0.2% | +940,205 |
| Vanguard Portfolio Management LLC | 3,707,327 | $1.6B | 0.1% | +21,834 |
| Jpmorgan Chase & Co | 3,373,844 | $1.4B | 0.1% | +1,277,502 |
| Vanguard Capital Management LLC | 3,049,560 | $1.4B | 0.0% | +35,359 |
| State Street Corp | 2,134,663 | $949.4M | 0.0% | +76,931 |
| Point72 Asset Management, L.P. | 1,996,843 | $888.2M | 1.4% | +386,512 |
| Capital International Investors | 1,915,187 | $851.9M | 0.2% | −53,583 |
| Geode Capital Management, LLC | 1,539,072 | $686.6M | 0.0% | −247 |
| Fmr LLC | 1,499,498 | $667.0M | 0.0% | −434,345 |
| Wellington Management Group Llp | 1,416,034 | $629.9M | 0.1% | −417,103 |
| Capital World Investors | 1,366,290 | $607.7M | 0.1% | +89,090 |
| Whale Rock Capital Management LLC | 1,271,373 | $565.5M | 4.5% | −35,351 |
| Neuberger Berman Group LLC | 1,165,068 | $518.2M | 0.3% | −268,461 |
| Alkeon Capital Management LLC | 1,072,040 | $476.8M | 1.8% | New |
| Norges Bank | 954,667 | $424.6M | 0.0% | New |
| Westfield Capital Management Co LP | 928,617 | $413.0M | 1.3% | −118,146 |
| Sachem Head Capital Management LP | 812,700 | $361.5M | 7.5% | New |
| Charles Schwab Investment Management Inc | 808,198 | $359.5M | 0.0% | −58,449 |
| Citadel Advisors LLC | 697,670 | $310.3M | 0.2% | −249,362 |
| Morgan Stanley | 681,576 | $303.2M | 0.0% | +166,513 |
| Bank of New York Mellon Corp | 658,544 | $292.9M | 0.0% | −173,606 |
| Millennium Management LLC | 645,071 | $286.9M | 0.2% | −249,298 |
| Aqr Capital Management LLC | 638,333 | $280.2M | 0.1% | +21,836 |
| Victory Capital Management Inc | 609,027 | $270.9M | 0.2% | −269,731 |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
6 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Oct 31, 2025 | Lisa C. McClainRepublican, House | Sale | $1,001 - $15,000 | −45.9% | Report |
| Oct 30, 2025 | Lisa C. McClainRepublican, House | Buy | $1,001 - $15,000 | +50.5% | Report |
| Oct 30, 2025 | Lisa C. McClainRepublican, House | Sale | $1,001 - $15,000 | −50.5% | Report |
| Aug 4, 2025 | Lisa C. McClainRepublican, House | Buy | $1,001 - $15,000 | +120.8% | Report |
| Apr 3, 2023 | Tommy TubervilleRepublican, Senate | Sale | $1,001 - $15,000 | −74.3% | Report |
| Mar 30, 2022 | Tommy TubervilleRepublican, Senate | Buy | $1,001 - $15,000 | −22.2% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
SEC filer profile
How MKS INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARMKS INC1
- CIK0001049502
- Employer ID (EIN)04-22775126
- Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company6
- Incorporated inMassachusetts6
- Fiscal year endsDecember 311
- Industry code (SIC)3823 Industrial Instruments For Measurement, Display, and Control1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address2 Tech Drive, Andover, MA 018101
- Phone978-645-55001
- Shares outstanding67,617,558 as of Jul 28, 202613
- Public float$6.7B as of Jun 30, 20256
- AuditorPricewaterhouseCoopers LLP, Boston, Massachusetts PCAOB ID 238; it also attests to the company’s internal control over financial reporting6
- On EDGAR sinceNov 14, 19971
- Filings2,476 in all: 4 (1,596), 8-K (231), SC 13G/A (104), 10-Q (83), 144 (76), 4/A (37), 3 (35), 5 (29)1
All 50 form types
DEF 14A (27), 10-K (26), CT ORDER (22), SC 13G (22), S-8 (20), DEFA14A (15), SC 13D/A (15), ARS (14), SD (13), UPLOAD (13), SCHEDULE 13G/A (11), CORRESP (10), 425 (8), 8-K/A (7), DFAN14A (7), PRE 14A (5), S-1/A (5), SC TO-I/A (5), SCHEDULE 13G (5), 5/A (4), 3/A (2), 424B5 (2), 424B7 (2), 8-A12G (2), REGDEX (2), RW (2), S-1 (2), S-3 (2), SC 13D (2), 10-K405 (1), 424B1 (1), DEFM14A (1), EFFECT (1), NT 10-K (1), POS AM (1), PREM14A (1), REGDEX/A (1), S-3/A (1), S-3ASR (1), S-4 (1), S-4/A (1), SC TO-I (1)
- Latest filingsAnnual report (10-K) Feb 24, 2026
Quarterly report (10-Q) Aug 6, 2026
Proxy statement (DEF 14A) Mar 31, 2026
Latest 8-K (8-K) Aug 5, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock | MKSI | Nasdaq Global Select Market |
From the cover page of the 10-K filed Feb 24, 2026 (Section 12(b) of the Exchange Act).6
Risk factors and legal proceedings
The risks MKS INC names in Item 1A of its 10-K filed Feb 24, 2026: 33 risks under these headings, as written.6
- Strategic Transaction Risks
- As part of our business strategy, we have consummated and may continue to pursue acquisitions and other strategic transactions, which may be challenging and costly to identify and complete, disruptive to our business and our management, and/or dilutive to stockholder value.
- Financial Risks
- Our substantial consolidated indebtedness could adversely affect us, including by increasing our interest expense and decreasing our business flexibility.
- The terms of our Term Loan Facility, Revolving Facility and 2034 Notes impose significant financial obligations and risks upon us, limit our ability to take certain actions, and could discourage a change in control.
- A material amount of our assets represents goodwill and intangible assets, against which we have recorded impairments in the past, and our net income may be significantly reduced by future impairments of these assets.
- Risks Related to Cybersecurity, Data Privacy and Intellectual Property Protection
- We are exposed to risks related to cybersecurity and data privacy threats and incidents, such as the ransomware event we identified in February 2023, and we are subject to restrictions and changes in laws and regulations governing data privacy and data protection, any of which could have a material adverse effect on our business.
- Our proprietary technology is important to the continued success of our business. Our failure to protect this proprietary technology may significantly impair our competitive position.
- Risks Related to Our Operations
- Supply chain disruptions and other manufacturing interruptions or delays have affected our ability to meet customer demand and have led to higher costs, while the failure to estimate customer demand accurately has resulted in excess or obsolete inventory, all of which has negatively impacted, and could in the future negatively impact, our business.
- Our dependence on sole and limited source suppliers and international suppliers has negatively impacted, and could continue to impact, our ability to manufacture products and systems.
The other 25 risks
- Our failure to successfully manage the transition of certain of our products to other manufacturing locations, the transition of certain of our products to or from contract manufacturers, and the transition of certain functions to centralized locations would likely harm our business, financial condition and operating results.
- Our products could contain defects, which would increase our costs and seriously harm our business, financial condition, operating results and customer relationships.
- Chemical manufacturing is inherently hazardous and could result in accidents that disrupt our operations or expose us to significant losses or liabilities.
- We outsource a number of services to third-party service providers, which decreases our control over the performance of these functions. Disruptions or delays at our third-party service providers could adversely impact our operations.
- The loss of net revenues from any of our major customers would likely have a material adverse effect on us.
- Key personnel have been, and may continue to be, difficult to attract and retain.
- Emerging issues related to the development, deployment, and use of AI, including generative AI, in our business could give rise to competitive disadvantages, reputational harm, legal or regulatory action, or other adverse impacts on our business.
- Risks Related to Our Industries and Markets
- The semiconductor, electronics manufacturing and automotive industries we serve are characterized by periodic fluctuations in business activity that may cause a reduction in demand for our products.
- Many of the markets and industries we serve are highly competitive, are subject to rapid technological advancement, and have narrow design windows, and if we fail to introduce new and innovative products or improve our existing products, or if our products or the applications we invest in do not achieve widespread adoption, our business, financial condition and operating results will be harmed.
- We offer products for multiple markets and must face the challenges of supporting the distinct needs of each of the markets we serve.
- Risks Related to Operating a Global Business
- We face significant risks associated with doing business internationally.
- We face significant risks associated with doing business in China in particular.
- Unfavorable currency exchange rate fluctuations may lead to lower operating results or may cause us to change customer pricing, which could result in reduced sales and losses.
- Legal, Tax, Regulatory and Compliance Risks
- We are obligated to develop and maintain proper and effective internal control over financial reporting, and we previously identified a material weakness in our internal control over financial reporting and may discover additional material weaknesses
- in the future. Any failure to maintain the adequacy of this internal control may adversely affect our operating results, our stock price and investor confidence in our Company.
- If significant trade restrictions or tariffs on our products or components that are imported from or exported to certain countries, including, but not limited to, China, are initiated, continue or are expanded, our business, financial condition and operating results may be materially harmed.
- We are subject to international trade compliance regulations, and violations of those regulations could result in fines or trade restrictions, which could have a material adverse effect on us.
- Changes in tax rates or tax regulation or the termination of tax incentives could affect our operating results.
- Many of our products and customers are subject to numerous laws regulating the production and use of chemical substances, and some of our products may need to be reformulated or discontinued to comply with these laws and regulations.
- We are subject to environmental regulations. If we fail to comply with these regulations, our business could be harmed.
- We are exposed to various risks related to legal proceedings, including, for example, product liability claims, intellectual property infringement claims, regulatory claims, contractual claims and class action litigation, which if successful, could have a material adverse effect on our commercial relationships, business, financial condition and operating results.
- Risks Related to Owning Our Common Stock
- Our quarterly operating results have fluctuated, and are likely to continue to vary significantly, which may result in volatility in the market price of our common stock.
- The market price of our common stock has fluctuated and may continue to fluctuate for reasons over which we have no control.
- We may not pay dividends on our common stock.
- Some provisions of our Restated Articles of Organization, our Second Amended and Restated By-laws, as amended, and Massachusetts law could discourage potential acquisition proposals and could delay, deter or prevent a change in control.
Legal proceedings
We are subject to various legal proceedings and claims, which have arisen in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on our results of operations, financial condition or cash flows.
The opening of Item 3, Legal Proceedings.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMKS INC filings on SEC EDGAR
- 2
- 3Yahoo FinanceMKSI quote
- 4SEC EDGARMKS INC filings on SEC EDGAR
- 5
- 6
- 7SEC EDGARMKS INC 10-K for fiscal 2025
- 8SEC EDGARMKS INC 10-K for fiscal 2019
- 9SEC EDGARMKS INC 10-K for fiscal 2020
- 10SEC EDGARMKS INC 10-K for fiscal 2021
- 11SEC EDGARMKS INC 10-K for fiscal 2022
- 12SEC EDGARMKS INC 10-Q for fiscal 2026
- 13SEC EDGARMKS INC 10-Q for fiscal 2026
- 14SEC EDGARMKS INC 10-K for fiscal 2019
- 15
- 16
- 17SEC EDGARJohn R. Bertucci, Chair
- 18SEC EDGARGerard G. Colella, President
- 19
- 20
- 21
- 22
- 23
- 24SEC EDGARRenee Martel Donlan, EVP, GC & CCO
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33SEC EDGARPaul Loomis, VP & GM, Astex
- 34
- 35
- 36
- 37
- 38SEC EDGARWissam G. Jabre, Board member
- 39SEC EDGARPeter Cannone Iii., Board member
- 40SEC EDGARJanice K. Henry, Board member
- 41SEC EDGARJoseph B. Donahue, Board member
- 42SEC EDGARMichelle M. Warner, Board member
- 43SEC EDGARRick D. Hess, Board member
- 44SEC EDGARJacqueline F. Moloney, Board member
- 45SEC EDGARRobert J. Phillippy, Board member
- 46SEC EDGARElizabeth Mora, Board member
- 47SEC EDGARPeter Hanley, Board member
- 48SEC EDGARCristina Amon, Board member
- 49SEC EDGARHans Jochen Kahl, Board member
- 50SEC EDGARRichard S. Chute, Board member
- 51SEC EDGAROwen W. Robbins, Board member
- 52SEC EDGARJames G. Berges, Board member
- 53SEC EDGARLouis P. Valente, Board member
- 54SEC EDGARJohn R. Bertucci, Board member
- 55SEC EDGARResults of operations
- 56
- 57SEC EDGARResults of operations
- 58SEC EDGARExecutive or director change
- 59SEC EDGARResults of operations
- 60
- 61SEC EDGAROther events
- 62
- 63SEC EDGARResults of operations
- 64SEC EDGARResults of operations
- 65
- 66SEC EDGARResults of operations
- 67NasdaqNasdaq calendar
- 68
- 69
- 70
- 71SEC EDGARFMR LLC SCHEDULE 13G/A on MKS INC
- 72
- 73
- 74
- 75
- 76SEC EDGARInvesco SCHEDULE 13G on MKS INC
- 77SEC EDGARBlackRock SCHEDULE 13G/A on MKS INC
- 78
- 79SEC EDGARCarlyle Group SC 13G/A on MKS INC
- 80
- 81